Ancora Medical

Ancora Heart is a clinical-stage medical technology company focused on developing minimally invasive treatments for heart failure and structural heart diseases. The company's flagship product, the AccuCinch Ventricular Restoration System, is designed to repair the enlarged left ventricle by reducing its size and supporting the heart wall. This percutaneous procedure aims to improve heart function and quality of life for patients with heart failure with reduced ejection fraction (HFrEF) who remain symptomatic despite guideline-directed medical therapy. Ancora Heart is currently conducting the CORCINCH-HF pivotal clinical trial to support FDA submission and commercialization.